Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5489)
All Articles published online
|
Publishing Process of This Article
|
Feb 7, 2013 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li DB, Ye F, Wu XR, Wu LP, Chen JX, Li B, Zhou YM. Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases. World J Gastroenterol 2013; 19(5): 761-768 [PMID: 23431050 DOI: 10.3748/wjg.v19.i5.761] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i5/761.htm |
| Number | Citing Articles |
| 1 |
Patrick Starlinger, Alice Assinger, Christine Brostjan, Thomas Gruenberger. Liver surgery for metastatic colorectal cancer: the surgical oncologist perspective. Colorectal Cancer 2016; 5(3): 115 doi: 10.2217/crc-2016-0004
|
| 2 |
Angela Lamarca, Jorge Barriuso, Amarjot Chander, Mairéad G McNamara, Richard A Hubner, Derek ÓReilly, Prakash Manoharan, Juan W Valle. 18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) for patients with biliary tract cancer: Systematic review and meta-analysis. Journal of Hepatology 2019; 71(1): 115 doi: 10.1016/j.jhep.2019.01.038
|
| 3 |
Ashton A. Connor, Ronald Burkes, Steven Gallinger. Strategies in the Multidisciplinary Management of Synchronous Colorectal Cancer and Resectable Liver Metastases. Current Colorectal Cancer Reports 2014; 10(2): 227 doi: 10.1007/s11888-014-0222-9
|
| 4 |
Donatella Marino, Francesco Leone, Francesca D’Avanzo, Dario Ribero, Lorenzo Capussotti, Massimo Aglietta. Potentially resectable metastatic colorectal cancer: An individualized approach to conversion therapy. Critical Reviews in Oncology/Hematology 2014; 92(3): 218 doi: 10.1016/j.critrevonc.2014.05.010
|
| 5 |
Cindy Neuzillet, Benoît Rousseau, Hemant Kocher, Philippe Bourget, Christophe Tournigand. Unravelling the pharmacologic opportunities and future directions for targeted therapies in gastro-intestinal cancers Part 1: GI carcinomas. Pharmacology & Therapeutics 2017; 174: 145 doi: 10.1016/j.pharmthera.2017.02.028
|
| 6 |
Chao Jiang, Xiao-Dong Sun, Wei Qiu, Yu-Guo Chen, Da-Wei Sun, Guo-Yue Lv. Conversion therapy in liver transplantation for hepatocellular carcinoma: What's new in the era of molecular and immune therapy?. Hepatobiliary & Pancreatic Diseases International 2023; 22(1): 7 doi: 10.1016/j.hbpd.2022.10.006
|
| 7 |
Christina E. Bailey, Alexander A. Parikh. Assessment of the risk of antiangiogenic agents before and after surgery. Cancer Treatment Reviews 2018; 68: 38 doi: 10.1016/j.ctrv.2018.05.002
|
| 8 |
Matthew D. Robinson, Mairéad G. McNamara, Hamish W. Clouston, Paul A. Sutton, Richard A. Hubner, Juan W. Valle. Patients Undergoing Systemic Anti-Cancer Therapy Who Require Surgical Intervention: What Surgeons Need to Know. Cancers 2023; 15(15): 3781 doi: 10.3390/cancers15153781
|
| 9 |
Yanming Zhou, Feng Yu, Lupeng Wu, Feng Ye, Leilei Zhang, Yumin Li. Survival after Gastrectomy in Node-Negative Gastric Cancer: A Review and Meta-Analysis of Prognostic Factors. Medical Science Monitor 2015; 21: 1911 doi: 10.12659/MSM.893856
|
| 10 |
Damien Bergeat, Michel Rayar, Yann Mouchel, Aude Merdrignac, Bernard Meunier, Astrid Lièvre, Karim Boudjema, Laurent Sulpice. Preoperative bevacizumab and surgery for colorectal liver metastases: a propensity score analysis. Langenbeck's Archives of Surgery 2017; 402(1): 57 doi: 10.1007/s00423-017-1551-3
|
| 11 |
Devron R. Shah, Shamik Dholakia, Rashmi R. Shah. Effect of Tyrosine Kinase Inhibitors on Wound Healing and Tissue Repair: Implications for Surgery in Cancer Patients. Drug Safety 2014; 37(3): 135 doi: 10.1007/s40264-014-0139-x
|
| 12 |
Amparo Valverde, Rubén Ciria, Javier Caballero-Villarraso, Patricia Aguilar-Melero, Gustavo Ferrín, Isidora Ranchal, Clara Linares, Carmen Herencia, Sandra González-Rubio, Manuel de la Mata, Álvaro Naranjo, Javier Briceño. Bevacizumab Allows Preservation of Liver Function and its Regenerative Capacity after Major Hepatectomy. Anti-Cancer Agents in Medicinal Chemistry 2019; 19(11): 1388 doi: 10.2174/1871520619666190417162409
|
| 13 |
Lu Wang, Yinan Sun, Ben Zhao, Huixian Zhang, Qianqian Yu, Xianglin Yuan. Chemotherapy plus targeted drugs in conversion therapy for potentially resectable colorectal liver metastases: a meta-analysis. Oncotarget 2016; 7(34): 55732 doi: 10.18632/oncotarget.9675
|
| 14 |
Alexandre A. Jácome, Fernanda A. Oliveira, Flora Lino, João Paulo S.N. Lima. Effect of Adding Bevacizumab to Chemotherapy on Pathologic Response to Preoperative Systemic Therapy for Resectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis. Clinical Colorectal Cancer 2021; 20(3): 265 doi: 10.1016/j.clcc.2021.05.006
|